With ever-increasing speed from DNA to IND, the window for toxicological data generation is becoming shorter and more critical. This necessitates innovative solutions to expedite the delivery of materials required for these vital studies, upon which an IND submission is dependent. Accelerating toxicology material delivery offers a promising pathway to accelerate a drug candidate’s entry into clinic. Newly developed timelines for rapid toxicology material delivery can be an effective way to reduce a drug candidate’s time to enter the clinic.
In this webinar, our experts explore the key strategies and technologies designed to address the analytical considerations and material flows to facilitate the rapid delivery of toxicological material. Here, we will be introducing our newly developed offerings, aimed to accelerate tox material generation by up to 50%, increasing the window for toxicology studies by two months and preventing delays in IND submission. Standard timelines for toxicology studies traditionally stand at four to five months. With increasing need to speed IND-enabling activities, we show how shifting the window for toxicology studies earlier alleviates this new potential bottleneck within Lonza programs.
In this webinar, you'll learn:
- Maximize speed: Discover our newly developed timelines that can reduce the time to deliver toxicology materials by up to 50%, giving you a head start on your IND submission.
- Ensure compliance: Confidently navigate the regulatory requirements for non-clinical material used in toxicology and IND-enabling studies.
- Enabling Technologies and Streamlined Analytics: Discover lean solutions and technologies that accelerate your material delivery process, along with efficient, robust analytical workflows for toxicology material characterization and release.
- Integrated drug substance/drug product offer: Applying this rapid toxicology material supply approach in rapid clinical timelines is achievable with this new integrated offering.